nodes	percent_of_prediction	percent_of_DWPC	metapath
Cysteamine—MPO—prostate cancer	0.582	1	CbGaD
Cysteamine—SST—prostate gland—prostate cancer	0.00753	0.262	CbGeAlD
Cysteamine—SST—epithelium—prostate cancer	0.00553	0.192	CbGeAlD
Cysteamine—SST—renal system—prostate cancer	0.00513	0.178	CbGeAlD
Cysteamine—SST—lymph node—prostate cancer	0.0024	0.0836	CbGeAlD
Cysteamine—MPO—epithelium—prostate cancer	0.00223	0.0775	CbGeAlD
Cysteamine—MPO—renal system—prostate cancer	0.00207	0.0719	CbGeAlD
Cysteamine—MPO—bone marrow—prostate cancer	0.00156	0.0543	CbGeAlD
Cysteamine—MPO—testis—prostate cancer	0.00134	0.0465	CbGeAlD
Cysteamine—MPO—lymph node—prostate cancer	0.000968	0.0337	CbGeAlD
Cysteamine—Affect lability—Doxorubicin—prostate cancer	0.000153	0.000701	CcSEcCtD
Cysteamine—Fatigue—Mitoxantrone—prostate cancer	0.000153	0.0007	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	0.000153	0.0007	CcSEcCtD
Cysteamine—Vomiting—Goserelin—prostate cancer	0.000153	0.000699	CcSEcCtD
Cysteamine—Discomfort—Etoposide—prostate cancer	0.000152	0.000696	CcSEcCtD
Cysteamine—Constipation—Mitoxantrone—prostate cancer	0.000152	0.000694	CcSEcCtD
Cysteamine—Rash—Goserelin—prostate cancer	0.000151	0.000693	CcSEcCtD
Cysteamine—Dermatitis—Goserelin—prostate cancer	0.000151	0.000692	CcSEcCtD
Cysteamine—Vomiting—Conjugated Estrogens—prostate cancer	0.000151	0.000692	CcSEcCtD
Cysteamine—Urticaria—Estradiol—prostate cancer	0.000151	0.000692	CcSEcCtD
Cysteamine—Mental disorder—Docetaxel—prostate cancer	0.000151	0.000692	CcSEcCtD
Cysteamine—Immune system disorder—Capecitabine—prostate cancer	0.000151	0.000691	CcSEcCtD
Cysteamine—Abdominal pain—Estradiol—prostate cancer	0.00015	0.000689	CcSEcCtD
Cysteamine—Body temperature increased—Estradiol—prostate cancer	0.00015	0.000689	CcSEcCtD
Cysteamine—Headache—Goserelin—prostate cancer	0.00015	0.000689	CcSEcCtD
Cysteamine—Malnutrition—Docetaxel—prostate cancer	0.00015	0.000688	CcSEcCtD
Cysteamine—Erythema—Docetaxel—prostate cancer	0.00015	0.000688	CcSEcCtD
Cysteamine—Rash—Conjugated Estrogens—prostate cancer	0.00015	0.000686	CcSEcCtD
Cysteamine—Dermatitis—Conjugated Estrogens—prostate cancer	0.00015	0.000686	CcSEcCtD
Cysteamine—Headache—Conjugated Estrogens—prostate cancer	0.000149	0.000682	CcSEcCtD
Cysteamine—Confusional state—Etoposide—prostate cancer	0.000149	0.000681	CcSEcCtD
Cysteamine—Hallucination—Prednisone—prostate cancer	0.000148	0.000678	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—CXCL12—prostate cancer	0.000148	0.000865	CbGpPWpGaD
Cysteamine—Anaphylactic shock—Etoposide—prostate cancer	0.000147	0.000675	CcSEcCtD
Cysteamine—Mood swings—Doxorubicin—prostate cancer	0.000147	0.000675	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—ANXA1—prostate cancer	0.000147	0.000859	CbGpPWpGaD
Cysteamine—Ataxia—Doxorubicin—prostate cancer	0.000146	0.00067	CcSEcCtD
Cysteamine—Mental disorder—Capecitabine—prostate cancer	0.000146	0.00067	CcSEcCtD
Cysteamine—Connective tissue disorder—Prednisone—prostate cancer	0.000146	0.000669	CcSEcCtD
Cysteamine—Feeling abnormal—Mitoxantrone—prostate cancer	0.000146	0.000669	CcSEcCtD
Cysteamine—SST—SIDS Susceptibility Pathways—IL6—prostate cancer	0.000145	0.000852	CbGpPWpGaD
Cysteamine—Erythema—Capecitabine—prostate cancer	0.000145	0.000666	CcSEcCtD
Cysteamine—Malnutrition—Capecitabine—prostate cancer	0.000145	0.000666	CcSEcCtD
Cysteamine—MPO—C-MYB transcription factor network—EP300—prostate cancer	0.000145	0.00085	CbGpPWpGaD
Cysteamine—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000145	0.000664	CcSEcCtD
Cysteamine—Dehydration—Doxorubicin—prostate cancer	0.000145	0.000663	CcSEcCtD
Cysteamine—Liver function test abnormal—Doxorubicin—prostate cancer	0.000144	0.000658	CcSEcCtD
Cysteamine—Skin disorder—Etoposide—prostate cancer	0.000143	0.000656	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—CALCA—prostate cancer	0.000143	0.000839	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PENK—prostate cancer	0.000143	0.000838	CbGpPWpGaD
Cysteamine—Nausea—Goserelin—prostate cancer	0.000143	0.000653	CcSEcCtD
Cysteamine—SST—Signaling Pathways—GHR—prostate cancer	0.000142	0.000834	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CXCL8—prostate cancer	0.000142	0.000833	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—IL6—prostate cancer	0.000142	0.00083	CbGpPWpGaD
Cysteamine—Nausea—Conjugated Estrogens—prostate cancer	0.000141	0.000647	CcSEcCtD
Cysteamine—Urticaria—Mitoxantrone—prostate cancer	0.000141	0.000645	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—PRKCQ—prostate cancer	0.000141	0.000824	CbGpPWpGaD
Cysteamine—Anorexia—Etoposide—prostate cancer	0.000141	0.000644	CcSEcCtD
Cysteamine—Hypersensitivity—Estradiol—prostate cancer	0.00014	0.000642	CcSEcCtD
Cysteamine—Body temperature increased—Mitoxantrone—prostate cancer	0.00014	0.000642	CcSEcCtD
Cysteamine—Abdominal pain—Mitoxantrone—prostate cancer	0.00014	0.000642	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—CXCL12—prostate cancer	0.00014	0.00082	CbGpPWpGaD
Cysteamine—Anaemia—Docetaxel—prostate cancer	0.000139	0.000636	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—CALCA—prostate cancer	0.000137	0.000805	CbGpPWpGaD
Cysteamine—Asthenia—Estradiol—prostate cancer	0.000137	0.000625	CcSEcCtD
Cysteamine—SST—Signaling Pathways—NRP1—prostate cancer	0.000136	0.000799	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GHR—prostate cancer	0.000136	0.000799	CbGpPWpGaD
Cysteamine—Tremor—Capecitabine—prostate cancer	0.000136	0.000624	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—PRKCQ—prostate cancer	0.000135	0.00079	CbGpPWpGaD
Cysteamine—Leukopenia—Docetaxel—prostate cancer	0.000134	0.000616	CcSEcCtD
Cysteamine—Anaemia—Capecitabine—prostate cancer	0.000134	0.000615	CcSEcCtD
Cysteamine—Immune system disorder—Prednisone—prostate cancer	0.000134	0.000615	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—CXCL12—prostate cancer	0.000134	0.000786	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—ADRB2—prostate cancer	0.000132	0.000774	CbGpPWpGaD
Cysteamine—Somnolence—Etoposide—prostate cancer	0.000131	0.0006	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—NRP1—prostate cancer	0.000131	0.000766	CbGpPWpGaD
Cysteamine—Hypersensitivity—Mitoxantrone—prostate cancer	0.000131	0.000598	CcSEcCtD
Cysteamine—Mental disorder—Prednisone—prostate cancer	0.00013	0.000597	CcSEcCtD
Cysteamine—Diarrhoea—Estradiol—prostate cancer	0.00013	0.000596	CcSEcCtD
Cysteamine—Leukopenia—Capecitabine—prostate cancer	0.00013	0.000596	CcSEcCtD
Cysteamine—Convulsion—Docetaxel—prostate cancer	0.00013	0.000596	CcSEcCtD
Cysteamine—Hypertension—Docetaxel—prostate cancer	0.00013	0.000594	CcSEcCtD
Cysteamine—Erythema—Prednisone—prostate cancer	0.00013	0.000593	CcSEcCtD
Cysteamine—Malnutrition—Prednisone—prostate cancer	0.00013	0.000593	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—VAV3—prostate cancer	0.000129	0.000755	CbGpPWpGaD
Cysteamine—Decreased appetite—Etoposide—prostate cancer	0.000128	0.000587	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—PRKCQ—prostate cancer	0.000128	0.000748	CbGpPWpGaD
Cysteamine—Renal failure—Epirubicin—prostate cancer	0.000127	0.000583	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Etoposide—prostate cancer	0.000127	0.000583	CcSEcCtD
Cysteamine—Asthenia—Mitoxantrone—prostate cancer	0.000127	0.000582	CcSEcCtD
Cysteamine—Fatigue—Etoposide—prostate cancer	0.000127	0.000582	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.000127	0.000581	CcSEcCtD
Cysteamine—SST—Signaling Pathways—VIP—prostate cancer	0.000127	0.000743	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—GNRH1—prostate cancer	0.000127	0.000743	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—ADRB2—prostate cancer	0.000127	0.000742	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—MYC—prostate cancer	0.000126	0.000741	CbGpPWpGaD
Cysteamine—Constipation—Etoposide—prostate cancer	0.000126	0.000577	CcSEcCtD
Cysteamine—MPO—Folate Metabolism—TP53—prostate cancer	0.000126	0.000738	CbGpPWpGaD
Cysteamine—Dizziness—Estradiol—prostate cancer	0.000126	0.000576	CcSEcCtD
Cysteamine—Hypertension—Capecitabine—prostate cancer	0.000126	0.000575	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—ITPR1—prostate cancer	0.000125	0.000732	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—TP53—prostate cancer	0.000124	0.000729	CbGpPWpGaD
Cysteamine—Confusional state—Docetaxel—prostate cancer	0.000124	0.000566	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—VAV3—prostate cancer	0.000124	0.000724	CbGpPWpGaD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	0.000123	0.000563	CcSEcCtD
Cysteamine—SST—Signaling Pathways—LPAR1—prostate cancer	0.000123	0.00072	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—GRP—prostate cancer	0.000123	0.00072	CbGpPWpGaD
Cysteamine—Anaphylactic shock—Docetaxel—prostate cancer	0.000123	0.000561	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—PRKCQ—prostate cancer	0.000122	0.000717	CbGpPWpGaD
Cysteamine—Discomfort—Capecitabine—prostate cancer	0.000122	0.00056	CcSEcCtD
Cysteamine—SST—Signaling Pathways—PLCB2—prostate cancer	0.000122	0.000712	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GNRH1—prostate cancer	0.000122	0.000712	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—VIP—prostate cancer	0.000122	0.000712	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—LRP2—prostate cancer	0.000122	0.000712	CbGpPWpGaD
Cysteamine—Feeling abnormal—Etoposide—prostate cancer	0.000122	0.000556	CcSEcCtD
Cysteamine—Diarrhoea—Mitoxantrone—prostate cancer	0.000121	0.000555	CcSEcCtD
Cysteamine—Vomiting—Estradiol—prostate cancer	0.000121	0.000554	CcSEcCtD
Cysteamine—Gastrointestinal pain—Etoposide—prostate cancer	0.000121	0.000552	CcSEcCtD
Cysteamine—Nervous system disorder—Docetaxel—prostate cancer	0.00012	0.00055	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—ADRB2—prostate cancer	0.00012	0.000703	CbGpPWpGaD
Cysteamine—Rash—Estradiol—prostate cancer	0.00012	0.000549	CcSEcCtD
Cysteamine—Dermatitis—Estradiol—prostate cancer	0.00012	0.000549	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—ITPR1—prostate cancer	0.00012	0.000702	CbGpPWpGaD
Cysteamine—Anaemia—Prednisone—prostate cancer	0.00012	0.000548	CcSEcCtD
Cysteamine—Confusional state—Capecitabine—prostate cancer	0.00012	0.000548	CcSEcCtD
Cysteamine—SST—Signaling Pathways—P4HB—prostate cancer	0.000119	0.000699	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CX3CL1—prostate cancer	0.000119	0.000699	CbGpPWpGaD
Cysteamine—Headache—Estradiol—prostate cancer	0.000119	0.000546	CcSEcCtD
Cysteamine—Skin disorder—Docetaxel—prostate cancer	0.000119	0.000545	CcSEcCtD
Cysteamine—Agitation—Prednisone—prostate cancer	0.000119	0.000545	CcSEcCtD
Cysteamine—Renal failure—Doxorubicin—prostate cancer	0.000118	0.00054	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—LPAR1—prostate cancer	0.000118	0.00069	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GRP—prostate cancer	0.000118	0.00069	CbGpPWpGaD
Cysteamine—Urticaria—Etoposide—prostate cancer	0.000117	0.000536	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—VAV3—prostate cancer	0.000117	0.000686	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—HIST1H2BG—prostate cancer	0.000117	0.000686	CbGpPWpGaD
Cysteamine—Anorexia—Docetaxel—prostate cancer	0.000117	0.000535	CcSEcCtD
Cysteamine—MPO—C-MYB transcription factor network—KRAS—prostate cancer	0.000117	0.000684	CbGpPWpGaD
Cysteamine—Abdominal pain—Etoposide—prostate cancer	0.000117	0.000534	CcSEcCtD
Cysteamine—Body temperature increased—Etoposide—prostate cancer	0.000117	0.000534	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—PLCB2—prostate cancer	0.000117	0.000683	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—LRP2—prostate cancer	0.000117	0.000683	CbGpPWpGaD
Cysteamine—Nervous system disorder—Capecitabine—prostate cancer	0.000116	0.000533	CcSEcCtD
Cysteamine—SST—Signaling Pathways—GRB7—prostate cancer	0.000116	0.00068	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PDE4D—prostate cancer	0.000116	0.00068	CbGpPWpGaD
Cysteamine—Skin disorder—Capecitabine—prostate cancer	0.000115	0.000528	CcSEcCtD
Cysteamine—MPO—Folate Metabolism—IL6—prostate cancer	0.000115	0.000675	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—ADRB2—prostate cancer	0.000115	0.000674	CbGpPWpGaD
Cysteamine—Urinary tract disorder—Epirubicin—prostate cancer	0.000115	0.000526	CcSEcCtD
Cysteamine—Connective tissue disorder—Epirubicin—prostate cancer	0.000114	0.000524	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—P4HB—prostate cancer	0.000114	0.00067	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CX3CL1—prostate cancer	0.000114	0.00067	CbGpPWpGaD
Cysteamine—Urethral disorder—Epirubicin—prostate cancer	0.000114	0.000522	CcSEcCtD
Cysteamine—NPY2R—Circadian rythm related genes—IL6—prostate cancer	0.000114	0.000667	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—ITPR1—prostate cancer	0.000114	0.000665	CbGpPWpGaD
Cysteamine—Anorexia—Capecitabine—prostate cancer	0.000113	0.000518	CcSEcCtD
Cysteamine—SST—Signaling Pathways—HIST1H4H—prostate cancer	0.000113	0.000662	CbGpPWpGaD
Cysteamine—Nausea—Estradiol—prostate cancer	0.000113	0.000518	CcSEcCtD
Cysteamine—SST—GPCR ligand binding—CXCL8—prostate cancer	0.000113	0.000662	CbGpPWpGaD
Cysteamine—Vomiting—Mitoxantrone—prostate cancer	0.000113	0.000516	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—VAV3—prostate cancer	0.000112	0.000657	CbGpPWpGaD
Cysteamine—Convulsion—Prednisone—prostate cancer	0.000112	0.000514	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—HIST1H2BG—prostate cancer	0.000112	0.000657	CbGpPWpGaD
Cysteamine—Hypertension—Prednisone—prostate cancer	0.000112	0.000512	CcSEcCtD
Cysteamine—Rash—Mitoxantrone—prostate cancer	0.000112	0.000512	CcSEcCtD
Cysteamine—Dermatitis—Mitoxantrone—prostate cancer	0.000112	0.000511	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—GRB7—prostate cancer	0.000111	0.000652	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PDE4D—prostate cancer	0.000111	0.000652	CbGpPWpGaD
Cysteamine—Headache—Mitoxantrone—prostate cancer	0.000111	0.000509	CcSEcCtD
Cysteamine—SST—Signaling Pathways—GNG5—prostate cancer	0.00011	0.000646	CbGpPWpGaD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.00011	0.000501	CcSEcCtD
Cysteamine—Somnolence—Docetaxel—prostate cancer	0.000109	0.000499	CcSEcCtD
Cysteamine—Discomfort—Prednisone—prostate cancer	0.000109	0.000499	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—ITPR1—prostate cancer	0.000109	0.000638	CbGpPWpGaD
Cysteamine—Hypersensitivity—Etoposide—prostate cancer	0.000109	0.000498	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—HIST1H4H—prostate cancer	0.000108	0.000635	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CXCL8—prostate cancer	0.000108	0.000635	CbGpPWpGaD
Cysteamine—Dyspepsia—Docetaxel—prostate cancer	0.000108	0.000494	CcSEcCtD
Cysteamine—Decreased appetite—Docetaxel—prostate cancer	0.000107	0.000488	CcSEcCtD
Cysteamine—Urinary tract disorder—Doxorubicin—prostate cancer	0.000106	0.000487	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000106	0.000485	CcSEcCtD
Cysteamine—Asthenia—Etoposide—prostate cancer	0.000106	0.000485	CcSEcCtD
Cysteamine—Connective tissue disorder—Doxorubicin—prostate cancer	0.000106	0.000484	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—GNG5—prostate cancer	0.000106	0.00062	CbGpPWpGaD
Cysteamine—Anaphylactic shock—Prednisone—prostate cancer	0.000106	0.000484	CcSEcCtD
Cysteamine—Fatigue—Docetaxel—prostate cancer	0.000106	0.000484	CcSEcCtD
Cysteamine—Urethral disorder—Doxorubicin—prostate cancer	0.000106	0.000483	CcSEcCtD
Cysteamine—Nausea—Mitoxantrone—prostate cancer	0.000105	0.000482	CcSEcCtD
Cysteamine—Immune system disorder—Epirubicin—prostate cancer	0.000105	0.000481	CcSEcCtD
Cysteamine—Constipation—Docetaxel—prostate cancer	0.000105	0.00048	CcSEcCtD
Cysteamine—Dyspepsia—Capecitabine—prostate cancer	0.000104	0.000478	CcSEcCtD
Cysteamine—Nervous system disorder—Prednisone—prostate cancer	0.000104	0.000475	CcSEcCtD
Cysteamine—Decreased appetite—Capecitabine—prostate cancer	0.000103	0.000472	CcSEcCtD
Cysteamine—Skin disorder—Prednisone—prostate cancer	0.000103	0.00047	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000102	0.000469	CcSEcCtD
Cysteamine—Fatigue—Capecitabine—prostate cancer	0.000102	0.000468	CcSEcCtD
Cysteamine—Mental disorder—Epirubicin—prostate cancer	0.000102	0.000467	CcSEcCtD
Cysteamine—Constipation—Capecitabine—prostate cancer	0.000101	0.000465	CcSEcCtD
Cysteamine—Malnutrition—Epirubicin—prostate cancer	0.000101	0.000464	CcSEcCtD
Cysteamine—Erythema—Epirubicin—prostate cancer	0.000101	0.000464	CcSEcCtD
Cysteamine—Feeling abnormal—Docetaxel—prostate cancer	0.000101	0.000462	CcSEcCtD
Cysteamine—Diarrhoea—Etoposide—prostate cancer	0.000101	0.000462	CcSEcCtD
Cysteamine—Anorexia—Prednisone—prostate cancer	0.000101	0.000461	CcSEcCtD
Cysteamine—Gastrointestinal pain—Docetaxel—prostate cancer	0.0001	0.000459	CcSEcCtD
Cysteamine—Tension—Epirubicin—prostate cancer	9.94e-05	0.000455	CcSEcCtD
Cysteamine—Nervousness—Epirubicin—prostate cancer	9.84e-05	0.00045	CcSEcCtD
Cysteamine—Feeling abnormal—Capecitabine—prostate cancer	9.78e-05	0.000448	CcSEcCtD
Cysteamine—Dizziness—Etoposide—prostate cancer	9.75e-05	0.000447	CcSEcCtD
Cysteamine—Immune system disorder—Doxorubicin—prostate cancer	9.73e-05	0.000445	CcSEcCtD
Cysteamine—Gastrointestinal pain—Capecitabine—prostate cancer	9.7e-05	0.000444	CcSEcCtD
Cysteamine—Abdominal pain—Docetaxel—prostate cancer	9.69e-05	0.000444	CcSEcCtD
Cysteamine—Body temperature increased—Docetaxel—prostate cancer	9.69e-05	0.000444	CcSEcCtD
Cysteamine—SST—Signaling Pathways—PTHLH—prostate cancer	9.61e-05	0.000563	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TGFBR1—prostate cancer	9.61e-05	0.000563	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—AKR1C3—prostate cancer	9.46e-05	0.000554	CbGpPWpGaD
Cysteamine—Mental disorder—Doxorubicin—prostate cancer	9.43e-05	0.000432	CcSEcCtD
Cysteamine—Urticaria—Capecitabine—prostate cancer	9.43e-05	0.000432	CcSEcCtD
Cysteamine—SST—Signaling Pathways—PRKACB—prostate cancer	9.41e-05	0.000551	CbGpPWpGaD
Cysteamine—Abdominal pain—Capecitabine—prostate cancer	9.38e-05	0.00043	CcSEcCtD
Cysteamine—Body temperature increased—Capecitabine—prostate cancer	9.38e-05	0.00043	CcSEcCtD
Cysteamine—Vomiting—Etoposide—prostate cancer	9.38e-05	0.000429	CcSEcCtD
Cysteamine—Erythema—Doxorubicin—prostate cancer	9.37e-05	0.000429	CcSEcCtD
Cysteamine—Malnutrition—Doxorubicin—prostate cancer	9.37e-05	0.000429	CcSEcCtD
Cysteamine—Anaemia—Epirubicin—prostate cancer	9.36e-05	0.000429	CcSEcCtD
Cysteamine—Agitation—Epirubicin—prostate cancer	9.31e-05	0.000426	CcSEcCtD
Cysteamine—Dyspepsia—Prednisone—prostate cancer	9.31e-05	0.000426	CcSEcCtD
Cysteamine—Rash—Etoposide—prostate cancer	9.3e-05	0.000426	CcSEcCtD
Cysteamine—Dermatitis—Etoposide—prostate cancer	9.29e-05	0.000425	CcSEcCtD
Cysteamine—Headache—Etoposide—prostate cancer	9.24e-05	0.000423	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—PTHLH—prostate cancer	9.22e-05	0.00054	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TGFBR1—prostate cancer	9.22e-05	0.00054	CbGpPWpGaD
Cysteamine—Tension—Doxorubicin—prostate cancer	9.2e-05	0.000421	CcSEcCtD
Cysteamine—Decreased appetite—Prednisone—prostate cancer	9.19e-05	0.000421	CcSEcCtD
Cysteamine—SST—Signaling Pathways—THBS1—prostate cancer	9.17e-05	0.000537	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PPP3CA—prostate cancer	9.17e-05	0.000537	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—IL6—prostate cancer	9.16e-05	0.000536	CbGpPWpGaD
Cysteamine—Fatigue—Prednisone—prostate cancer	9.11e-05	0.000417	CcSEcCtD
Cysteamine—Nervousness—Doxorubicin—prostate cancer	9.1e-05	0.000417	CcSEcCtD
Cysteamine—Leukopenia—Epirubicin—prostate cancer	9.07e-05	0.000415	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—AKR1C3—prostate cancer	9.07e-05	0.000531	CbGpPWpGaD
Cysteamine—Constipation—Prednisone—prostate cancer	9.04e-05	0.000414	CcSEcCtD
Cysteamine—SST—Signaling Pathways—ANXA1—prostate cancer	9.04e-05	0.000529	CbGpPWpGaD
Cysteamine—Hypersensitivity—Docetaxel—prostate cancer	9.03e-05	0.000413	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—PRKACB—prostate cancer	9.02e-05	0.000528	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PRKCZ—prostate cancer	8.87e-05	0.00052	CbGpPWpGaD
Cysteamine—Asthenia—Docetaxel—prostate cancer	8.79e-05	0.000403	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—THBS1—prostate cancer	8.79e-05	0.000515	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PPP3CA—prostate cancer	8.79e-05	0.000515	CbGpPWpGaD
Cysteamine—Convulsion—Epirubicin—prostate cancer	8.78e-05	0.000402	CcSEcCtD
Cysteamine—Nausea—Etoposide—prostate cancer	8.76e-05	0.000401	CcSEcCtD
Cysteamine—Hypertension—Epirubicin—prostate cancer	8.75e-05	0.0004	CcSEcCtD
Cysteamine—Hypersensitivity—Capecitabine—prostate cancer	8.74e-05	0.0004	CcSEcCtD
Cysteamine—Feeling abnormal—Prednisone—prostate cancer	8.71e-05	0.000399	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—PIK3CG—prostate cancer	8.67e-05	0.000508	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—ANXA1—prostate cancer	8.66e-05	0.000508	CbGpPWpGaD
Cysteamine—Anaemia—Doxorubicin—prostate cancer	8.66e-05	0.000397	CcSEcCtD
Cysteamine—Gastrointestinal pain—Prednisone—prostate cancer	8.64e-05	0.000396	CcSEcCtD
Cysteamine—Agitation—Doxorubicin—prostate cancer	8.61e-05	0.000394	CcSEcCtD
Cysteamine—SST—Signaling Pathways—PARP1—prostate cancer	8.57e-05	0.000502	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—FGFR4—prostate cancer	8.57e-05	0.000502	CbGpPWpGaD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	8.57e-05	0.000392	CcSEcCtD
Cysteamine—Discomfort—Epirubicin—prostate cancer	8.52e-05	0.00039	CcSEcCtD
Cysteamine—Asthenia—Capecitabine—prostate cancer	8.52e-05	0.00039	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—PRKCZ—prostate cancer	8.5e-05	0.000498	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CALCA—prostate cancer	8.46e-05	0.000496	CbGpPWpGaD
Cysteamine—Urticaria—Prednisone—prostate cancer	8.4e-05	0.000385	CcSEcCtD
Cysteamine—Leukopenia—Doxorubicin—prostate cancer	8.39e-05	0.000384	CcSEcCtD
Cysteamine—Diarrhoea—Docetaxel—prostate cancer	8.39e-05	0.000384	CcSEcCtD
Cysteamine—Body temperature increased—Prednisone—prostate cancer	8.36e-05	0.000383	CcSEcCtD
Cysteamine—Abdominal pain—Prednisone—prostate cancer	8.36e-05	0.000383	CcSEcCtD
Cysteamine—Confusional state—Epirubicin—prostate cancer	8.34e-05	0.000382	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—PIK3CG—prostate cancer	8.31e-05	0.000487	CbGpPWpGaD
Cysteamine—Anaphylactic shock—Epirubicin—prostate cancer	8.27e-05	0.000379	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CXCL12—prostate cancer	8.27e-05	0.000484	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PARP1—prostate cancer	8.21e-05	0.000481	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—FGFR4—prostate cancer	8.21e-05	0.000481	CbGpPWpGaD
Cysteamine—Convulsion—Doxorubicin—prostate cancer	8.12e-05	0.000372	CcSEcCtD
Cysteamine—Diarrhoea—Capecitabine—prostate cancer	8.12e-05	0.000372	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—CALCA—prostate cancer	8.11e-05	0.000475	CbGpPWpGaD
Cysteamine—Nervous system disorder—Epirubicin—prostate cancer	8.11e-05	0.000371	CcSEcCtD
Cysteamine—Dizziness—Docetaxel—prostate cancer	8.11e-05	0.000371	CcSEcCtD
Cysteamine—Hypertension—Doxorubicin—prostate cancer	8.09e-05	0.000371	CcSEcCtD
Cysteamine—Skin disorder—Epirubicin—prostate cancer	8.03e-05	0.000368	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	7.93e-05	0.000363	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—CXCL12—prostate cancer	7.92e-05	0.000464	CbGpPWpGaD
Cysteamine—Discomfort—Doxorubicin—prostate cancer	7.88e-05	0.000361	CcSEcCtD
Cysteamine—Anorexia—Epirubicin—prostate cancer	7.88e-05	0.000361	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—PIK3CG—prostate cancer	7.87e-05	0.000461	CbGpPWpGaD
Cysteamine—Dizziness—Capecitabine—prostate cancer	7.85e-05	0.000359	CcSEcCtD
Cysteamine—Vomiting—Docetaxel—prostate cancer	7.79e-05	0.000357	CcSEcCtD
Cysteamine—Hypersensitivity—Prednisone—prostate cancer	7.79e-05	0.000357	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CASP9—prostate cancer	7.78e-05	0.000456	CbGpPWpGaD
Cysteamine—Rash—Docetaxel—prostate cancer	7.73e-05	0.000354	CcSEcCtD
Cysteamine—Dermatitis—Docetaxel—prostate cancer	7.72e-05	0.000354	CcSEcCtD
Cysteamine—Confusional state—Doxorubicin—prostate cancer	7.71e-05	0.000353	CcSEcCtD
Cysteamine—Headache—Docetaxel—prostate cancer	7.68e-05	0.000352	CcSEcCtD
Cysteamine—Anaphylactic shock—Doxorubicin—prostate cancer	7.65e-05	0.00035	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—PIK3CD—prostate cancer	7.62e-05	0.000447	CbGpPWpGaD
Cysteamine—Asthenia—Prednisone—prostate cancer	7.58e-05	0.000347	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—PIK3CG—prostate cancer	7.55e-05	0.000442	CbGpPWpGaD
Cysteamine—Vomiting—Capecitabine—prostate cancer	7.55e-05	0.000345	CcSEcCtD
Cysteamine—SST—Signaling Pathways—PRKCQ—prostate cancer	7.54e-05	0.000442	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NGFR—prostate cancer	7.54e-05	0.000442	CbGpPWpGaD
Cysteamine—Nervous system disorder—Doxorubicin—prostate cancer	7.5e-05	0.000343	CcSEcCtD
Cysteamine—Rash—Capecitabine—prostate cancer	7.48e-05	0.000343	CcSEcCtD
Cysteamine—Dermatitis—Capecitabine—prostate cancer	7.48e-05	0.000342	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—CASP9—prostate cancer	7.46e-05	0.000437	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MAP3K7—prostate cancer	7.45e-05	0.000437	CbGpPWpGaD
Cysteamine—Headache—Capecitabine—prostate cancer	7.43e-05	0.00034	CcSEcCtD
Cysteamine—Skin disorder—Doxorubicin—prostate cancer	7.43e-05	0.00034	CcSEcCtD
Cysteamine—Somnolence—Epirubicin—prostate cancer	7.35e-05	0.000337	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—PIK3CD—prostate cancer	7.31e-05	0.000428	CbGpPWpGaD
Cysteamine—Anorexia—Doxorubicin—prostate cancer	7.29e-05	0.000334	CcSEcCtD
Cysteamine—Nausea—Docetaxel—prostate cancer	7.28e-05	0.000333	CcSEcCtD
Cysteamine—Dyspepsia—Epirubicin—prostate cancer	7.28e-05	0.000333	CcSEcCtD
Cysteamine—Diarrhoea—Prednisone—prostate cancer	7.23e-05	0.000331	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—PRKCQ—prostate cancer	7.23e-05	0.000424	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NGFR—prostate cancer	7.23e-05	0.000424	CbGpPWpGaD
Cysteamine—Decreased appetite—Epirubicin—prostate cancer	7.19e-05	0.000329	CcSEcCtD
Cysteamine—SST—Signaling Pathways—FGF10—prostate cancer	7.17e-05	0.00042	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MAP3K7—prostate cancer	7.15e-05	0.000419	CbGpPWpGaD
Cysteamine—Gastrointestinal disorder—Epirubicin—prostate cancer	7.14e-05	0.000327	CcSEcCtD
Cysteamine—Fatigue—Epirubicin—prostate cancer	7.13e-05	0.000326	CcSEcCtD
Cysteamine—SST—Signaling Pathways—ADRB2—prostate cancer	7.09e-05	0.000415	CbGpPWpGaD
Cysteamine—Constipation—Epirubicin—prostate cancer	7.07e-05	0.000324	CcSEcCtD
Cysteamine—Nausea—Capecitabine—prostate cancer	7.05e-05	0.000323	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—JAK2—prostate cancer	7e-05	0.00041	CbGpPWpGaD
Cysteamine—Dizziness—Prednisone—prostate cancer	6.99e-05	0.00032	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—MAP2K1—prostate cancer	6.97e-05	0.000408	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PIK3CD—prostate cancer	6.92e-05	0.000405	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—VAV3—prostate cancer	6.92e-05	0.000405	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—FGF10—prostate cancer	6.87e-05	0.000402	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TGFBR2—prostate cancer	6.82e-05	0.000399	CbGpPWpGaD
Cysteamine—Feeling abnormal—Epirubicin—prostate cancer	6.81e-05	0.000312	CcSEcCtD
Cysteamine—Somnolence—Doxorubicin—prostate cancer	6.8e-05	0.000311	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—ADRB2—prostate cancer	6.8e-05	0.000398	CbGpPWpGaD
Cysteamine—Gastrointestinal pain—Epirubicin—prostate cancer	6.76e-05	0.00031	CcSEcCtD
Cysteamine—Dyspepsia—Doxorubicin—prostate cancer	6.73e-05	0.000308	CcSEcCtD
Cysteamine—Vomiting—Prednisone—prostate cancer	6.72e-05	0.000308	CcSEcCtD
Cysteamine—SST—Signaling Pathways—ITPR1—prostate cancer	6.71e-05	0.000393	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—JAK2—prostate cancer	6.71e-05	0.000393	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—MAP2K1—prostate cancer	6.68e-05	0.000391	CbGpPWpGaD
Cysteamine—Rash—Prednisone—prostate cancer	6.67e-05	0.000305	CcSEcCtD
Cysteamine—Dermatitis—Prednisone—prostate cancer	6.66e-05	0.000305	CcSEcCtD
Cysteamine—Decreased appetite—Doxorubicin—prostate cancer	6.65e-05	0.000304	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—PIK3CB—prostate cancer	6.64e-05	0.000389	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PIK3CD—prostate cancer	6.64e-05	0.000389	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—VAV3—prostate cancer	6.63e-05	0.000388	CbGpPWpGaD
Cysteamine—Headache—Prednisone—prostate cancer	6.62e-05	0.000303	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Doxorubicin—prostate cancer	6.6e-05	0.000302	CcSEcCtD
Cysteamine—Fatigue—Doxorubicin—prostate cancer	6.6e-05	0.000302	CcSEcCtD
Cysteamine—Urticaria—Epirubicin—prostate cancer	6.57e-05	0.000301	CcSEcCtD
Cysteamine—Constipation—Doxorubicin—prostate cancer	6.54e-05	0.0003	CcSEcCtD
Cysteamine—Abdominal pain—Epirubicin—prostate cancer	6.54e-05	0.000299	CcSEcCtD
Cysteamine—Body temperature increased—Epirubicin—prostate cancer	6.54e-05	0.000299	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—TGFBR2—prostate cancer	6.54e-05	0.000383	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—ITPR1—prostate cancer	6.43e-05	0.000377	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IGF1R—prostate cancer	6.41e-05	0.000376	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—CXCL8—prostate cancer	6.38e-05	0.000374	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—PIK3CB—prostate cancer	6.37e-05	0.000373	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—JAK2—prostate cancer	6.35e-05	0.000372	CbGpPWpGaD
Cysteamine—Feeling abnormal—Doxorubicin—prostate cancer	6.3e-05	0.000289	CcSEcCtD
Cysteamine—Nausea—Prednisone—prostate cancer	6.28e-05	0.000287	CcSEcCtD
Cysteamine—Gastrointestinal pain—Doxorubicin—prostate cancer	6.26e-05	0.000286	CcSEcCtD
Cysteamine—SST—Signaling Pathways—LPL—prostate cancer	6.15e-05	0.00036	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IGF1R—prostate cancer	6.15e-05	0.00036	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—CXCL8—prostate cancer	6.12e-05	0.000359	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—IL2—prostate cancer	6.1e-05	0.000357	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PDGFRB—prostate cancer	6.09e-05	0.000357	CbGpPWpGaD
Cysteamine—Hypersensitivity—Epirubicin—prostate cancer	6.09e-05	0.000279	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—JAK2—prostate cancer	6.09e-05	0.000357	CbGpPWpGaD
Cysteamine—Urticaria—Doxorubicin—prostate cancer	6.08e-05	0.000278	CcSEcCtD
Cysteamine—Abdominal pain—Doxorubicin—prostate cancer	6.05e-05	0.000277	CcSEcCtD
Cysteamine—Body temperature increased—Doxorubicin—prostate cancer	6.05e-05	0.000277	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—PIK3CB—prostate cancer	6.03e-05	0.000353	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—ITGB3—prostate cancer	5.94e-05	0.000348	CbGpPWpGaD
Cysteamine—Asthenia—Epirubicin—prostate cancer	5.93e-05	0.000272	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—LPL—prostate cancer	5.89e-05	0.000345	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—IL2—prostate cancer	5.85e-05	0.000343	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PDGFRB—prostate cancer	5.84e-05	0.000342	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CXCL8—prostate cancer	5.8e-05	0.00034	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PIK3CB—prostate cancer	5.78e-05	0.000339	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—ERBB3—prostate cancer	5.76e-05	0.000337	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—FGFR2—prostate cancer	5.75e-05	0.000337	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—ITGB3—prostate cancer	5.69e-05	0.000334	CbGpPWpGaD
Cysteamine—Diarrhoea—Epirubicin—prostate cancer	5.66e-05	0.000259	CcSEcCtD
Cysteamine—Hypersensitivity—Doxorubicin—prostate cancer	5.64e-05	0.000258	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—CXCL8—prostate cancer	5.56e-05	0.000326	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—IL2—prostate cancer	5.54e-05	0.000325	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—ERBB3—prostate cancer	5.52e-05	0.000324	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TERT—prostate cancer	5.52e-05	0.000323	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—FGFR2—prostate cancer	5.51e-05	0.000323	CbGpPWpGaD
Cysteamine—Asthenia—Doxorubicin—prostate cancer	5.49e-05	0.000251	CcSEcCtD
Cysteamine—Dizziness—Epirubicin—prostate cancer	5.47e-05	0.00025	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—IL2—prostate cancer	5.31e-05	0.000311	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TERT—prostate cancer	5.29e-05	0.00031	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—HIF1A—prostate cancer	5.28e-05	0.000309	CbGpPWpGaD
Cysteamine—Vomiting—Epirubicin—prostate cancer	5.26e-05	0.000241	CcSEcCtD
Cysteamine—Diarrhoea—Doxorubicin—prostate cancer	5.23e-05	0.00024	CcSEcCtD
Cysteamine—Rash—Epirubicin—prostate cancer	5.21e-05	0.000239	CcSEcCtD
Cysteamine—Dermatitis—Epirubicin—prostate cancer	5.21e-05	0.000238	CcSEcCtD
Cysteamine—Headache—Epirubicin—prostate cancer	5.18e-05	0.000237	CcSEcCtD
Cysteamine—SST—Signaling Pathways—LEP—prostate cancer	5.15e-05	0.000302	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CAV1—prostate cancer	5.11e-05	0.000299	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—HIF1A—prostate cancer	5.06e-05	0.000297	CbGpPWpGaD
Cysteamine—Dizziness—Doxorubicin—prostate cancer	5.06e-05	0.000232	CcSEcCtD
Cysteamine—SST—Signaling Pathways—KDR—prostate cancer	5.05e-05	0.000296	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—LEP—prostate cancer	4.94e-05	0.000289	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—ESR1—prostate cancer	4.92e-05	0.000288	CbGpPWpGaD
Cysteamine—Nausea—Epirubicin—prostate cancer	4.91e-05	0.000225	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—CAV1—prostate cancer	4.9e-05	0.000287	CbGpPWpGaD
Cysteamine—Vomiting—Doxorubicin—prostate cancer	4.86e-05	0.000223	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—KDR—prostate cancer	4.84e-05	0.000284	CbGpPWpGaD
Cysteamine—Rash—Doxorubicin—prostate cancer	4.82e-05	0.000221	CcSEcCtD
Cysteamine—Dermatitis—Doxorubicin—prostate cancer	4.82e-05	0.000221	CcSEcCtD
Cysteamine—SST—Signaling Pathways—BAD—prostate cancer	4.8e-05	0.000281	CbGpPWpGaD
Cysteamine—Headache—Doxorubicin—prostate cancer	4.79e-05	0.000219	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—ESR1—prostate cancer	4.72e-05	0.000276	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—APC—prostate cancer	4.65e-05	0.000272	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PIK3CG—prostate cancer	4.65e-05	0.000272	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—BAD—prostate cancer	4.6e-05	0.00027	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IRS1—prostate cancer	4.6e-05	0.000269	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—EGF—prostate cancer	4.6e-05	0.000269	CbGpPWpGaD
Cysteamine—Nausea—Doxorubicin—prostate cancer	4.54e-05	0.000208	CcSEcCtD
Cysteamine—SST—Signaling Pathways—GSK3B—prostate cancer	4.46e-05	0.000261	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PIK3CG—prostate cancer	4.46e-05	0.000261	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—APC—prostate cancer	4.46e-05	0.000261	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—EGF—prostate cancer	4.41e-05	0.000258	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IRS1—prostate cancer	4.41e-05	0.000258	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—INS—prostate cancer	4.4e-05	0.000258	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CREBBP—prostate cancer	4.31e-05	0.000253	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GSK3B—prostate cancer	4.28e-05	0.000251	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IGF1—prostate cancer	4.26e-05	0.000249	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—EGFR—prostate cancer	4.24e-05	0.000248	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—INS—prostate cancer	4.22e-05	0.000247	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CREBBP—prostate cancer	4.13e-05	0.000242	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MAP2K1—prostate cancer	4.12e-05	0.000241	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PIK3CD—prostate cancer	4.09e-05	0.00024	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IGF1—prostate cancer	4.08e-05	0.000239	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—EGFR—prostate cancer	4.06e-05	0.000238	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—PIK3CA—prostate cancer	4.05e-05	0.000237	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—SERPINE1—prostate cancer	4.04e-05	0.000237	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—KRAS—prostate cancer	4e-05	0.000235	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MAP2K1—prostate cancer	3.95e-05	0.000231	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PIK3CD—prostate cancer	3.92e-05	0.00023	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—FGF2—prostate cancer	3.92e-05	0.000229	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—PIK3CA—prostate cancer	3.88e-05	0.000227	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—SERPINE1—prostate cancer	3.88e-05	0.000227	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NOS3—prostate cancer	3.86e-05	0.000226	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—KRAS—prostate cancer	3.84e-05	0.000225	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—FGF2—prostate cancer	3.75e-05	0.00022	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—JAK2—prostate cancer	3.75e-05	0.00022	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NOS3—prostate cancer	3.7e-05	0.000217	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PIK3CA—prostate cancer	3.68e-05	0.000215	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MDM2—prostate cancer	3.66e-05	0.000215	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—ERBB2—prostate cancer	3.61e-05	0.000212	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—JAK2—prostate cancer	3.6e-05	0.000211	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PIK3CB—prostate cancer	3.56e-05	0.000209	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PIK3CA—prostate cancer	3.53e-05	0.000207	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MDM2—prostate cancer	3.51e-05	0.000206	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—ERBB2—prostate cancer	3.46e-05	0.000203	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CXCL8—prostate cancer	3.42e-05	0.000201	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PIK3CB—prostate cancer	3.42e-05	0.0002	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CDKN1B—prostate cancer	3.34e-05	0.000196	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—AKT1—prostate cancer	3.31e-05	0.000194	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CXCL8—prostate cancer	3.28e-05	0.000192	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CASP3—prostate cancer	3.28e-05	0.000192	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IL2—prostate cancer	3.27e-05	0.000192	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—IL6—prostate cancer	3.26e-05	0.000191	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CDKN1B—prostate cancer	3.21e-05	0.000188	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CCND1—prostate cancer	3.19e-05	0.000187	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—AKT1—prostate cancer	3.17e-05	0.000186	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CTNNB1—prostate cancer	3.16e-05	0.000185	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CASP3—prostate cancer	3.14e-05	0.000184	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IL2—prostate cancer	3.14e-05	0.000184	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—IL6—prostate cancer	3.12e-05	0.000183	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MMP9—prostate cancer	3.1e-05	0.000181	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CDKN1A—prostate cancer	3.09e-05	0.000181	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PTEN—prostate cancer	3.08e-05	0.00018	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CCND1—prostate cancer	3.06e-05	0.000179	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CTNNB1—prostate cancer	3.03e-05	0.000177	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—AKT1—prostate cancer	3e-05	0.000176	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MMP9—prostate cancer	2.97e-05	0.000174	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CDKN1A—prostate cancer	2.96e-05	0.000173	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PTEN—prostate cancer	2.95e-05	0.000173	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—EP300—prostate cancer	2.94e-05	0.000172	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—AKT1—prostate cancer	2.88e-05	0.000169	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—SRC—prostate cancer	2.86e-05	0.000167	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—EP300—prostate cancer	2.82e-05	0.000165	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—VEGFA—prostate cancer	2.78e-05	0.000163	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—STAT3—prostate cancer	2.75e-05	0.000161	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—SRC—prostate cancer	2.74e-05	0.00016	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—VEGFA—prostate cancer	2.67e-05	0.000156	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—STAT3—prostate cancer	2.64e-05	0.000155	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MYC—prostate cancer	2.56e-05	0.00015	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TGFB1—prostate cancer	2.55e-05	0.00015	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—EGFR—prostate cancer	2.5e-05	0.000147	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MYC—prostate cancer	2.45e-05	0.000144	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TGFB1—prostate cancer	2.45e-05	0.000143	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—EGFR—prostate cancer	2.4e-05	0.000141	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—KRAS—prostate cancer	2.36e-05	0.000139	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—KRAS—prostate cancer	2.27e-05	0.000133	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PIK3CA—prostate cancer	2.17e-05	0.000127	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TP53—prostate cancer	2.1e-05	0.000123	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PIK3CA—prostate cancer	2.08e-05	0.000122	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TP53—prostate cancer	2.02e-05	0.000118	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IL6—prostate cancer	1.92e-05	0.000113	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IL6—prostate cancer	1.84e-05	0.000108	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—AKT1—prostate cancer	1.77e-05	0.000104	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—AKT1—prostate cancer	1.7e-05	9.97e-05	CbGpPWpGaD
